
The founders of LifeChart
Ayurveda are Mukul Shah and Mansi Sharma. With this new investment, Lifechart
aims to enhance its AI-driven diagnostic capabilities, launch new proprietary
solutions, and build a dedicated brand targeting tier-1 cities. The startup is
focused on addressing India’s growing gut health issues by offering products
and solutions crafted by doctors from BAMS (Bachelor of Ayurvedic Medicine and
Surgery) and BHMS (Bachelor of Homeopathic Medicine and Surgery).These
offerings include plant-based microbiome-focused products and wellness kits
aimed at common gut ailments like constipation, fatty liver, piles, gas, and
acidity.
Homegrown full-stack gut wellness brand Lifechart has raised $500,000
in the latest funding round led by Prajay Advisors LLP and various other
investors. The $500,000 raised in this round saw a $250,000 investment from
Prajay Advisors LLP, with Cignas from NA Shah Advisors LLP serving as the
transaction advisor. The remaining amount was secured through contributions from
Agility Ventures, Expert Dojo, and several angel investors, including Ahana
Gautam, Nitish Mittersain (Founder of Nazara Technologies Pvt. Ltd.), Sarath
Sura (Founder of Sunn91 Ventures), and Marwari Angels. Notably, the investments
were made using convertible instruments, which were converted into equity in
this round. In addition, Lifechart had previously secured $200,000 in a pre-seed
round from Expert Dojo and Nitish Mittersain in 2022."We are proud to have
attracted the trust of marquee investors, especially during a funding winter.
The new capital will be used to enhance our AI capabilities, launch our
proprietary diagnostic solutions, and build a new brand targeting Tier 1
cities," said Mukul Shah, CEO and Co-founder of Lifechart. Lifechart is
leveraging its technology and expertise to reach underserved regions in India.
The startup claims to have impacted over 250,000 customers, primarily from tier
II, III, and IV cities.
To cater to the growing
demand, the startup is hiring 50 in-house BAMS and BHMS doctors, further
enhancing its capacity to deliver effective solutions. It is also developing
India’s first gut wellness clinics and supermarkets, with plans to open 150
clinics over the next three years. The initiative aims to create a robust
infrastructure for gut health diagnostics and treatment across both urban and
rural areas. "Our vision is not just to sell products but to focus on
diagnosing and treating gut health issues, which is a critical unmet need in
India. This is what sets us apart from competitors," Shah added. Currently,
Lifechart is in talks to raise an additional $1–$2 million through inbound
interest from a venture capital firm based in Delhi NCR. The startup aims to
use these funds to expand its full-stack model further and grow its presence in
tier-1 cities with its new product line and clinic expansions. Industry reports
estimate that the global gut health market could reach $18 billion by 2025–26.
With its comprehensive diagnostic and treatment solutions, Lifechart is
positioning itself to capture a significant share of this expanding market. Prakash
Mody (Founder of Unichem Laboratory) and Jayendra Shah, Founders of Prajay LLP
said in a joint statement that “Gut health is a growing concern not only in
India but throughout the world. We are quite excited the way Lifechart with its
unique technology & fullstack approach is solving this huge problem. We
have full confidence in Mukul’s vision & execution abilities as he has been
a serial entrepreneur in the past &
has successfully built YoloBus (India’s leading Intercity Bus
platform) & got it successfully acquired.”